165 related articles for article (PubMed ID: 22205303)
1. Histone deacetylase 2 is upregulated in normal and keloid scars.
Fitzgerald O'Connor EJ; Badshah II; Addae LY; Kundasamy P; Thanabalasingam S; Abioye D; Soldin M; Shaw TJ
J Invest Dermatol; 2012 Apr; 132(4):1293-6. PubMed ID: 22205303
[No Abstract] [Full Text] [Related]
2. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.
Naim R; Naumann A; Barnes J; Sauter A; Hormann K; Merkel D; Aust W; Braun T; Bloching M
Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663
[TBL] [Abstract][Full Text] [Related]
3. [Implication of blood fibrocytes in trauma, development of scar and keloid].
Petrovich IuA; Iarema IV; Kichenko SM; Gurin AN
Patol Fiziol Eksp Ter; 2008; (4):31-4. PubMed ID: 19198271
[No Abstract] [Full Text] [Related]
4. Analysis of protease-activated receptor-1 and -2 in human scar formation.
Materazzi S; Pellerito S; Di Serio C; Paglierani M; Naldini A; Ardinghi C; Carraro F; Geppetti P; Cirino G; Santucci M; Tarantini F; Massi D
J Pathol; 2007 Aug; 212(4):440-9. PubMed ID: 17597495
[TBL] [Abstract][Full Text] [Related]
5. [The forensic medical and clinico-morphological aspects of the study of skin scars].
Serebrennikov IM
Sud Med Ekspert; 1992; 35(1):40-3. PubMed ID: 1589895
[No Abstract] [Full Text] [Related]
6. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation.
Hsu YC; Hsiao M; Wang LF; Chien YW; Lee WR
Nitric Oxide; 2006 Jun; 14(4):327-34. PubMed ID: 16517189
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts.
Diao JS; Xia WS; Yi CG; Wang YM; Li B; Xia W; Liu B; Guo SZ; Sun XD
Arch Dermatol Res; 2011 Oct; 303(8):573-80. PubMed ID: 21400246
[TBL] [Abstract][Full Text] [Related]
9. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
Carroll LA; Koch RJ
Med Sci Monit; 2003 Mar; 9(3):BR97-108. PubMed ID: 12640331
[TBL] [Abstract][Full Text] [Related]
10. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
11. Different metabolism of hexose sugars and sucrose in wound fluid and in fibroblast cultures derived from granulation tissue, hypertrophic scar and keloid.
Kössi J; Laato M
Pathobiology; 2000; 68(1):29-35. PubMed ID: 10859528
[TBL] [Abstract][Full Text] [Related]
12. The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics.
Tredget EE
Ann Plast Surg; 1994 Aug; 33(2):152-4. PubMed ID: 7979046
[No Abstract] [Full Text] [Related]
13. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro.
Diegelmann RF; Cohen IK; McCoy BJ
J Cell Physiol; 1979 Feb; 98(2):341-6. PubMed ID: 422662
[TBL] [Abstract][Full Text] [Related]
14. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
15. [Hypertrophic scar and keloid. I. Etiology, pathogenesis, pathology].
Salamon A
Morphol Igazsagugyi Orv Sz; 1984 Oct; 24(4):262-7. PubMed ID: 6513952
[No Abstract] [Full Text] [Related]
16. Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring.
Mori R; Tanaka K; de Kerckhove M; Okamoto M; Kashiyama K; Tanaka K; Kim S; Kawata T; Komatsu T; Park S; Ikematsu K; Hirano A; Martin P; Shimokawa I
Am J Pathol; 2014 Sep; 184(9):2465-79. PubMed ID: 25010393
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous scars: Part I.
Sahl WJ; Clever H
Int J Dermatol; 1994 Oct; 33(10):681-91. PubMed ID: 8002135
[No Abstract] [Full Text] [Related]
18. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hyaluronan and TSG-6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin.
Tan KT; McGrouther DA; Day AJ; Milner CM; Bayat A
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):317-27. PubMed ID: 20642475
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of α
Drummond PD; Dawson LF; Wood FM; Fear MW
Burns; 2018 May; 44(3):582-588. PubMed ID: 29089212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
